info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asia Pacific Lancet Pen Needels Companies

Companies involved in the production and distribution of lancets and pen needles in the Asia-Pacific region play a crucial role in providing essential tools for diabetes management and blood glucose monitoring. Lancets are small, sharp instruments used to prick the skin for blood sampling, while pen needles are used in insulin pens for injecting insulin.

Lancet and Pen Needles Market

 


Latest Asia Pacific lancet and pen needles Companies Updates:


Terumo Corporation partners with HTL-Strefa S.A.: This November 2023 collaboration aims to expand Terumo's reach in the European lancet and pen needles market, leveraging HTL-Strefa's expertise and distribution network.


Owen Mumford Ltd. acquires Jiangsu Hengrui Medicine's diabetes care business: This December 2023 acquisition strengthens Owen Mumford's presence in the Chinese market, a key driver of growth in the APAC region.


BD (Becton, Dickinson and Company) launches SoloStar insulin delivery system in Japan: This October 2023 launch offers a user-friendly pen needle option for patients with diabetes in Japan.


Ypsomed develops smart pen needles with integrated sensors: These innovative needles have the potential to improve insulin dosing accuracy and diabetes management through data collection and insights.


List of Asia Pacific lancet and pen needles Key companies in the market:



  • BD. (U.S.)

  • Novo Nordisk A/S (Europe)

  • Ypsomed (Europe)

  • B. Braun Melsungen AG (Europe)

  • HTL-STREFA (Europe)

  • Terumo Corporation (Asia Pacific)

  • Artsana S.p.A. (Europe)

  • Owen Mumford Ltd. (Europe)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.